Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $3.77M 40.6K sh | Sep 18, 2026 |
| 34 | Konowiecki Joseph SDirector, EVP, Corporate Affairs |  ALHCAlignment Healthcare, Inc.Open-market sale | SELL | $202K 23.5K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 32 | Allen William TDirector |  SVVSavers Value Village, Inc.Open-market sale | SELL | $241K 26.2K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 31 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $3.04M 33.2K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 31 | Aviv David MelehChief Technology Officer |  RDWRRADWARE LTDOpen-market sale | SELL | $461K 15.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 30 | Cislini JeffSVP & General Counsel |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $660K 3,314 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 29 | Saunders Scott JDirector |  NUTXNutex Health Inc.Open-market sale | SELL | $43K 203 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 29 | Graves Jeffrey ADirector, President and CEO |  DDD3D SYSTEMS CORPOpen-market sale | SELL | $152K 42.7K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 29 | Nordstrom Phyllis BEVP, CFO and CAO | DDD3D SYSTEMS CORP Open-market sale | SELL | $107K 30.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 28 | MacKay Craig CDirector |  EQHEquitable Holdings, Inc.Open-market sale | SELL | $109K 2,000 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 28 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $301K 3,039 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 28 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $407K 4,141 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 27 | Rosen TamiDirector |  PGYPagaya Technologies Ltd.Open-market sale · 10b5-1 plan | SELL | $173K 8,504 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 26 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $796K 3,992 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 26 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 26 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $4.10M 27.3K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 26 | Imberman AlanCFO and Treasurer | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $773K 76.5K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 26 | Zage George Raymond IIIDirector, 10% Owner |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $5.21M 333.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 26 | Bartolucci Ryan MChief Accounting Officer |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $530K 7,062 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 25 | Roger LisaFormer Chief Financial Officer |  BRFHBARFRESH FOOD GROUP INC.Open-market sale | SELL | $28K 25.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 25 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $148K 1,525 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 25 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $155K 1,648 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 | Sanfrey Jeffrey ScottChief Operating Officer |  BLBDBlue Bird CorpOpen-market sale | SELL | $250K 4,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 24 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $77K 1,800 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 23 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $67K 336 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $55K 586 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $144K 1,470 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $52K 541 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Fortunato DavidDirector, CEO and President | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $507K 50.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Wetterwald JulienChief Technology Officer | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $264K 26.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $14K 148 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $107K 1,079 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $348K 1,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Open-market sale | SELL | $34K 800 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 20 | Cislini JeffSVP & General Counsel | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Open-market sale · 10b5-1 plan | SELL | $155K 1,020 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 12.3K sh | Sep 18, 2026 traded Sep 17, 2026 |